IPO Details
Bidding Dates
25 Mar 25 - 27 Mar 25
Lot Size
1200
Price Range ₹
113 - 119
Exchange Status
NSE
Total Equity
₹ 73.81Cr
IPO Doc
IPO Timeline
Listing
--
Offer start
25 Mar 2025
Offer end
27 Mar 2025
Allotment
28 Mar 2025
Refund initiation
01 Apr 2025
Demat transfer
01 Apr 2025
Listing
--
Offer start
25 Mar 2025
Offer end
27 Mar 2025
Allotment
28 Mar 2025
Refund initiation
01 Apr 2025
Demat transfer
01 Apr 2025
About Company
Incorporated in 1990, Shri Ahimsa Naturals Limited specializes in the extraction and manufacturing of Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, while also trading various other herbal extracts. The company's products are widely used in the food & beverage, nutraceutical, cosmetics, and pharmaceutical industries due to their health benefits. Its product portfolio includes: Natural caffeine, which is extracted from plant seeds such as coffee and tea. It is used in energy drinks, soft drinks, cosmetics, and pharmaceuticals. Green coffee bean extract, which is derived from unroasted green coffee beans. It is rich in chlorogenic acid, known for its antioxidant properties and potential weight management benefits. The company exports its products to various countries, including the USA, Germany, South Korea, the UK, and Thailand. For the period ending September 30, 2024, the company's export revenue (including deemed exports) stood at ₹3,530.91 lakhs, with ₹7,463.71 lakhs recorded in Fiscal 2023, ₹9,988.01 lakhs in Fiscal 2022, and ₹5,633.50 lakhs in Fiscal 2021. Shri Ahimsa Naturals Limited's manufacturing facility is located in Jaipur, Rajasthan, and adheres to multiple quality and safety standards, including ISO 9001:2015 (Quality Management System), ISO 22000:2018 (Food Safety Management System), ISO 45001:2018 (Occupational Health & Safety Management System), ISO 14001:2015 (Environmental Management System), as well as HACCP and GMP guidelines. As of March 2025, the company had a workforce of approximately 80 employees.
Year Founded
17-10-1990
Promotor Details
Nemi Chand Jain
Promoter Holdings Details
| Particular | Pre-IPO | Post-IPO |
|---|---|---|
| Percentage | 41.89 | 0 |
| Share Capital | 8013250 | 0 |
Offer to Public
62,02,800.00 Cr
Project Details
- Investment in our Wholly-Owned Subsidiary, Shri Ahimsa Healthcare Private Limited (SAHPL) for settin - 350cr
Objectives
- Investment in our Wholly-Owned Subsidiary, Shri Ahimsa Healthcare Private Limited (SAHPL) for setting up a manufacturing facility at Sawarda, Jaipur, Rajasthan.General Corporate Purpose
Highlights
- The company operates in a niche segment, concentrating on natural caffeine to meet the increasing global demand for clean-label and plant-based ingredients.
- Its products adhere to food and pharmaceutical standards set by multiple international regulators, allowing access to diverse global markets.
- Shri Ahimsa Naturals has developed a unique process to produce high-purity caffeine (≥99%) from sustainable sources like coffee waste, ensuring superior quality and eco-friendliness.
- The company's manufacturing process is designed for cost efficiency while maintaining environmental compliance, offering a competitive advantage over synthetic caffeine producers.
- It is expanding its supplier base to enhance raw material availability and minimize dependency on limited sources, ensuring business continuity and scalability.
Challenges
- The company operates from a single manufacturing unit in Jaipur, Rajasthan, making it vulnerable to regional risks, natural disruptions, and operational challenges.
- Any malfunction or breakdown in manufacturing equipment could lead to production halts, increased repair costs, and potential delays in fulfilling orders.
- The upcoming manufacturing facility is also planned in Jaipur, further increasing the company's dependence on a single geographic location.
- Unavailability of electricity or labor shortages could impact production continuity, leading to delays in deliveries and potential revenue loss.
- The company's operations depend on an uninterrupted power supply from local utilities, making it susceptible to fluctuations or shortages that could affect manufacturing efficiency.
Financials
| Years | Total Assets | Share Capital | Profit After Tax | Consolidated Net Profit | Adjusted EPS |
|---|---|---|---|---|---|
| 2022 | 40,57,96,400.00 | 5,23,50,000.00 | 1,870.08 | 1,870.08 | 10.2065 |
| 2024 | 10,314.51 | 1,832.25 | 3,820.80 | 3,820.80 | 20.853 |
| 2023 | 7,412.67 | 523.50 | 11,26,58,104.00 | 11,26,58,104.00 | 6.1486 |
